Jolie gene drug trial 'impressive'

A new cancer drug for patients with the same faulty gene as actress Angelina Jolie has shown “impressive responses” in a clinical trial, researchers have said.

The potential drug, called BMN 673, targets DNA repair in cancer cells and is designed to attack tumours that have been left vulnerable by genetic mutations.